From stage I to stage III in CRC, the expression of KDM2B was higher in tumor tissues than that of the corresponding adjacent-normal tissues in each stage, and this difference exhibited an important significance in stages I–II and stage II than stage II–III + III. Here, KDM2B is linked to colorectal carcinoma.